2024 Q2 Form 10-Q Financial Statement

#000107125524000063 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $167.3M $174.0M $278.1M
YoY Change -41.63% -37.4% 1.61%
Cost Of Revenue $74.30M $81.38M $159.6M
YoY Change -54.22% -49.0% 3.91%
Gross Profit $93.03M $92.67M $118.5M
YoY Change -25.21% -21.8% -1.33%
Gross Profit Margin 55.6% 53.24% 42.62%
Selling, General & Admin $56.09M $59.99M $62.04M
YoY Change -16.58% -3.3% 1.85%
% of Gross Profit 60.29% 64.73% 52.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $22.00M $21.60M $22.20M
YoY Change 2.54% -2.7% -9.02%
% of Gross Profit 23.65% 23.31% 18.74%
Operating Expenses $56.09M $59.99M $62.04M
YoY Change -36.76% -3.3% 1.85%
Operating Profit $13.54M $80.14M $32.65M
YoY Change -62.09% 145.46% -0.72%
Interest Expense -$8.610M -$10.69M -$18.24M
YoY Change -54.21% -41.4% 20.62%
% of Operating Profit -63.61% -13.33% -55.85%
Other Income/Expense, Net -$13.06M -$10.69M -$18.24M
YoY Change -32.03% -41.4% 19.2%
Pretax Income $479.0K $69.46M $14.41M
YoY Change -97.1% 381.86% -18.04%
Income Tax -$144.0K $27.49M $2.784M
% Of Pretax Income -30.06% 39.58% 19.31%
Net Earnings $623.0K $41.96M $11.63M
YoY Change -94.93% 260.82% -67.75%
Net Earnings / Revenue 0.37% 24.11% 4.18%
Basic Earnings Per Share $0.02 $1.46 $0.41
Diluted Earnings Per Share $0.02 $1.37 $0.38
COMMON SHARES
Basic Shares Outstanding 28.95M shares 28.67M shares 28.18M shares
Diluted Shares Outstanding 30.23M shares 30.68M shares 30.90M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $88.64M $404.3M $110.5M
YoY Change -26.64% 266.0% -45.39%
Cash & Equivalents $88.64M $404.3M $110.5M
Short-Term Investments
Other Short-Term Assets $585.0K $530.0K $8.234M
YoY Change 3.54% -93.56% 158.61%
Inventory $7.032M $7.277M $7.239M
Prepaid Expenses $17.01M $19.93M $21.26M
Receivables $16.85M $17.69M $15.10M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $130.1M $449.8M $455.7M
YoY Change -71.08% -1.29% 76.84%
LONG-TERM ASSETS
Property, Plant & Equipment $862.2M $868.7M $812.3M
YoY Change 5.76% 6.95% -8.79%
Goodwill $88.31M $84.33M $80.75M
YoY Change 9.36% 4.43% -49.02%
Intangibles $55.35M $53.47M $49.72M
YoY Change 12.11% 7.54% -48.3%
Long-Term Investments
YoY Change
Other Assets $7.860M $8.287M $9.000M
YoY Change -16.01% -7.92% -23.75%
Total Long-Term Assets $1.051B $1.052B $1.044B
YoY Change 0.66% 0.76% -22.45%
TOTAL ASSETS
Total Short-Term Assets $130.1M $449.8M $455.7M
Total Long-Term Assets $1.051B $1.052B $1.044B
Total Assets $1.181B $1.502B $1.500B
YoY Change -20.95% 0.14% -6.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.70M $28.34M $17.72M
YoY Change 0.96% 59.89% -25.79%
Accrued Expenses $39.46M $48.18M $36.68M
YoY Change 36.86% 31.35% -22.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.699M $5.199M $477.0K
YoY Change 262.58% 989.94% -27.18%
Total Short-Term Liabilities $169.3M $190.2M $161.9M
YoY Change 13.17% 17.49% 20.19%
LONG-TERM LIABILITIES
Long-Term Debt $388.2M $660.9M $901.4M
YoY Change -56.65% -26.68% -8.63%
Other Long-Term Liabilities $250.0K $289.0K $448.0K
YoY Change -38.57% -35.49% -70.19%
Total Long-Term Liabilities $250.0K $289.0K $448.0K
YoY Change -38.57% -35.49% -70.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $169.3M $190.2M $161.9M
Total Long-Term Liabilities $250.0K $289.0K $448.0K
Total Liabilities $642.2M $932.3M $1.147B
YoY Change -42.98% -18.75% -9.72%
SHAREHOLDERS EQUITY
Retained Earnings $60.18M $96.20M -$115.8M
YoY Change -158.14% -183.08% -15.91%
Common Stock $478.9M $473.4M $468.3M
YoY Change 1.55% 1.1% -0.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $539.0M $569.6M $352.5M
YoY Change
Total Liabilities & Shareholders Equity $1.181B $1.502B $1.500B
YoY Change -20.95% 0.14% -6.5%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $623.0K $41.96M $11.63M
YoY Change -94.93% 260.82% -67.75%
Depreciation, Depletion And Amortization $22.00M $21.60M $22.20M
YoY Change 2.54% -2.7% -9.02%
Cash From Operating Activities $21.50M $25.80M $54.55M
YoY Change -53.58% -52.71% 25.34%
INVESTING ACTIVITIES
Capital Expenditures $17.59M $16.26M $25.07M
YoY Change -39.08% -35.15% 131.87%
Acquisitions
YoY Change
Other Investing Activities -$8.041M $204.9M $211.0K
YoY Change -10151.25% 96989.1% 134.44%
Cash From Investing Activities -$25.63M $188.6M -$24.86M
YoY Change -10.99% -858.61% 131.85%
FINANCING ACTIVITIES
Cash Dividend Paid $7.200M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -311.6M -$7.656M -$15.52M
YoY Change 3695.94% -50.66% -69.61%
NET CHANGE
Cash From Operating Activities 21.50M $25.80M $54.55M
Cash From Investing Activities -25.63M $188.6M -$24.86M
Cash From Financing Activities -311.6M -$7.656M -$15.52M
Net Change In Cash -315.7M $206.7M $14.17M
YoY Change -3489.16% 1359.09% -177.61%
FREE CASH FLOW
Cash From Operating Activities $21.50M $25.80M $54.55M
Capital Expenditures $17.59M $16.26M $25.07M
Free Cash Flow $3.912M $9.536M $29.47M
YoY Change -77.57% -67.65% -9.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28949000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28949000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28669000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28669000 shares
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
174047000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278051000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4080000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3830000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59987000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62036000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22120000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23508000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-14000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
86000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
69736000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 us-gaap Pre Opening Costs
PreOpeningCosts
139000 usd
CY2023Q1 us-gaap Pre Opening Costs
PreOpeningCosts
384000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
93905000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
245401000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
80142000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
32650000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10686000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18236000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10686000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18236000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69456000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14414000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27493000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2784000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
41963000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11630000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28724000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28308000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30679000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30904000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.46
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.37
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
352920000 usd
CY2023Q1 gden Stock Issued During Period Value Stock Options Exercised And Restricted Stock Units Vested
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsVested
6000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3290000 usd
CY2023Q1 gden Apic Share Based Compensation Income Tax Benefit
APICShareBasedCompensationIncomeTaxBenefit
-15373000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11630000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
352473000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
537733000 usd
CY2024Q1 gden Stock Issued During Period Value Stock Options Exercised And Restricted Stock Units Vested
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockUnitsVested
3000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3041000 usd
CY2024Q1 gden Apic Share Based Compensation Income Tax Benefit
APICShareBasedCompensationIncomeTaxBenefit
-5881000 usd
CY2024Q1 us-gaap Dividends
Dividends
7237000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
569622000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
41963000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11630000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22120000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23508000 usd
CY2024Q1 gden Lease Noncash Expense
LeaseNoncashExpense
-85000 usd
CY2023Q1 gden Lease Noncash Expense
LeaseNoncashExpense
33000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3041000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3290000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
937000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1079000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-14000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
86000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
69736000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
232000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7843000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
251000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2691000 usd
CY2024Q1 gden Increase Decrease In Prepaid Expense Inventories And Other Current Assets
IncreaseDecreaseInPrepaidExpenseInventoriesAndOtherCurrentAssets
-53000 usd
CY2023Q1 gden Increase Decrease In Prepaid Expense Inventories And Other Current Assets
IncreaseDecreaseInPrepaidExpenseInventoriesAndOtherCurrentAssets
-6690000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2492000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-144000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3263000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5434000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
35198000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-446000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-99000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25795000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
54546000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16259000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25072000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
211000 usd
CY2024Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
204858000 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
188599000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24861000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
440000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
24000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
338000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
125000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5881000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15373000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7656000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15516000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
206738000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14169000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
197600000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
142034000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
404338000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
156203000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
8386000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11109000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
3631000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7421000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2342000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3098000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
110000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
404300000 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51819 shares
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
1305073000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
1281708000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
515516000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
495563000 usd
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
789557000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
786145000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
21600000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
22200000 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
84325000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
84325000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
54790000 usd
CY2024Q1 gden Impairment Of Intangible Assets Indefinite Lived Excluding Goodwill Cumulative
ImpairmentOfIntangibleAssetsIndefiniteLivedExcludingGoodwillCumulative
6890000 usd
CY2024Q1 gden Indefinite Lived Intangible Assets Excluding Goodwill Net
IndefiniteLivedIntangibleAssetsExcludingGoodwillNet
47900000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
49663000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44094000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5569000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
104453000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44094000 usd
CY2024Q1 gden Impairment Of Intangible Assets Indefinite Lived Excluding Goodwill Cumulative
ImpairmentOfIntangibleAssetsIndefiniteLivedExcludingGoodwillCumulative
6890000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53469000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
54790000 usd
CY2023Q4 gden Impairment Of Intangible Assets Indefinite Lived Excluding Goodwill Cumulative
ImpairmentOfIntangibleAssetsIndefiniteLivedExcludingGoodwillCumulative
6890000 usd
CY2023Q4 gden Indefinite Lived Intangible Assets Excluding Goodwill Net
IndefiniteLivedIntangibleAssetsExcludingGoodwillNet
47900000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
49663000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
43628000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6035000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
104453000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
43628000 usd
CY2023Q4 gden Impairment Of Intangible Assets Indefinite Lived Excluding Goodwill Cumulative
ImpairmentOfIntangibleAssetsIndefiniteLivedExcludingGoodwillCumulative
6890000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53935000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
CY2024Q1 gden Accrued Gaming Liabilities
AccruedGamingLiabilities
10838000 usd
CY2023Q4 gden Accrued Gaming Liabilities
AccruedGamingLiabilities
10726000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
9931000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4572000 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
7893000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
7755000 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
7237000 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 usd
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
5780000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
5193000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4384000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4538000 usd
CY2024Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
2118000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1855000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48181000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34639000 usd
CY2024Q1 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
276453000 usd
CY2023Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
276453000 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
4983000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1691000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
222000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
438000 usd
CY2024Q1 gden Debt Instrument Carrying Amount Including Finance Lease Obligations
DebtInstrumentCarryingAmountIncludingFinanceLeaseObligations
678658000 usd
CY2023Q4 gden Debt Instrument Carrying Amount Including Finance Lease Obligations
DebtInstrumentCarryingAmountIncludingFinanceLeaseObligations
676582000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6921000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7423000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5664000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6042000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
666073000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
663117000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
5199000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4596000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
660874000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
658521000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0 usd
CY2024Q1 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
276500000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
90900000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1911354 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.19
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.51
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1898354 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.18
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
174047000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1898354 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.18
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4348412 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1146766 shares
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.396
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27500000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2800000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7200000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
700000 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
7900000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7200000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
700000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278051000 usd
CY2024Q1 gden Adjusted Ebitda
AdjustedEBITDA
40992000 usd
CY2023Q1 gden Adjusted Ebitda
AdjustedEBITDA
62167000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
22120000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
23508000 usd
CY2024Q1 gden Lease Noncash Expense
LeaseNoncashExpense
-85000 usd
CY2023Q1 gden Lease Noncash Expense
LeaseNoncashExpense
33000 usd
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3269000 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3893000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-14000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
86000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
69736000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2024Q1 gden Preopening And Related Expenses
PreopeningAndRelatedExpenses
139000 usd
CY2023Q1 gden Preopening And Related Expenses
PreopeningAndRelatedExpenses
384000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5129000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1785000 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10686000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18236000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27493000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2784000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
41963000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11630000 usd
CY2024Q1 us-gaap Assets
Assets
1501931000 usd
CY2023Q4 us-gaap Assets
Assets
1452283000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001071255-24-000063-index-headers.html Edgar Link pending
0001071255-24-000063-index.html Edgar Link pending
0001071255-24-000063.txt Edgar Link pending
0001071255-24-000063-xbrl.zip Edgar Link pending
a33124ex311.htm Edgar Link pending
a33124ex312.htm Edgar Link pending
a33124ex321.htm Edgar Link pending
ex101secondamendedandresta.htm Edgar Link pending
ex102amendedandrestatedarc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gden-20240331.htm Edgar Link pending
gden-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
gden-20240331_cal.xml Edgar Link unprocessable
gden-20240331_def.xml Edgar Link unprocessable
gden-20240331_lab.xml Edgar Link unprocessable
gden-20240331_pre.xml Edgar Link unprocessable
gden-20240331_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable